FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
DelMar Pharmaceuticals to Present Updated Phase I/II Clinical Data on VAL-083 in the Treatment of Refractory Glioblastoma Multiforme at GBM2015: 2nd International Symposium on Clinical and Basic Inve
July 09, 2015
SeeThruEquity Issues Update on DelMar Pharmaceuticals Highlighting Encouraging Efficacy Data Presented at ASCO
June 25, 2015
DelMar Pharmaceuticals Invited to Present at The World NSCLC Summit on June 23-24, 2015
June 15, 2015
DelMar Pharmaceuticals to Present at the BIO International Convention on June 17, 2015
June 10, 2015
Del Mar Pharmaceuticals Inc. (DMPI) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10
June 04, 2015
DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO
June 01, 2015
Addressing Treatment Resistant Brain Cancer through Development of Promising Drug Candidate
July 01, 2015
DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme
June 01, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here